Tech Company Financing Transactions
RxREVU Funding Round
RxREVU, operating out of Denver, secured $4.7 million from private investors.
Transaction Overview
Company Name
Announced On
1/7/2017
Transaction Type
Venture Equity
Amount
$4,737,107
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 44 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2601 Blake St. 450
Denver, CO 80205
USA
Denver, CO 80205
USA
Phone
Website
Email Address
Overview
RxREVU has over 6,000 cost-saving recommendations covering all of the major brand name chronic medications. The system uses twelve different cost-saving strategies to arrive at the most complete medication optimization solution available to healthcare portals and mobile applications today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Stephen McHale
Chief Executive Officer
Carm Huntress
Chief Financial Officer
Aaron Cornell
Chief Operating Officer
Christie Callahan
Chief Technical Officer
Gabe Hesse
President
Kyle Kiser
VP - Bus. Development
Benton Barney
Browse more venture capital transactions:
Prev: 1/7/2017: Jupiter Orphan Therapeutics venture capital transaction
Next: 1/7/2017: Microbion venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs